Management of drug-related problems including drug-drug interactions caused by nirmatrelvir/ritonavir in paediatric patients with SARS-CoV-2

被引：2
|
作者：
Yalcin, Nadir [1 ,2 ]
Demirkan, Kutay [1 ]
机构：
[1] Hacettepe Univ, Dept Clin Pharm, Fac Pharm, TR-06100 Ankara, Turkey
[2] Erasmus MC, Dept Clin Pharm, Rotterdam, Netherlands
来源：
ARCHIVES OF DISEASE IN CHILDHOOD | 2023年 / 108卷 / 10期
关键词：
pharmacology; infectious disease medicine; global health;
D O I：
10.1136/archdischild-2022-324168
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pharmacovigilance of Drug-Drug Interactions with Nirmatrelvir/Ritonavir
    Hendrick, Victoria
    Pohorylo, Erast
    Merchant, Lubna
    Gerhart, Jackie
    Arham, Iqra Naz
    Draica, Florin
    Quercia, Romina
    Ayoub, Ayman
    Mehta, Reema
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (12) : 2545 - 2561
  • [2] Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications
    Agarwal, Shubham
    Agarwal, Sanjeev Kumar
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (03) : 427 - 440
  • [3] Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications
    Shubham Agarwal
    Sanjeev Kumar Agarwal
    Cardiovascular Drugs and Therapy, 2021, 35 : 427 - 440
  • [4] Pharmacist's role in the management of drug-drug interactions caused by nirmatrelvir/ritonavir in COVID-19 oncohematology patients
    Cordero, Carlos Guzman
    de Vicente, Maria Saez-Torres
    Espinosa, Alvaro Jimenez
    Sanchez, Ana Isabel Gago
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [5] Nirmatrelvir/ritonavir drug-drug interactions in primary care outpatients
    Esquiroz, Andrea Rodriguez
    Alvarez, Lorea Sanz
    Marin, Marta Marin
    Gonzalez, Patricia Garcia
    Cobos, Paula Aldave
    Parra, Javier Garjon
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2023, 46 (03)
  • [6] Safely Prescribing Nirmatrelvir and Ritonavir-Avoiding Drug-Drug Interactions
    Culas, Roshni
    Nath, Sridesh
    Nath, Sarath
    JAMA INTERNAL MEDICINE, 2023, 183 (04) : 362 - 363
  • [7] Strategies for Avoiding Typical Drug-Drug Interactions and Drug-Related Problems in Patients with Vascular Diseases
    Schmelzer, Klaus Peter
    Liebetrau, Dominik
    Kaemmerer, Wolfgang
    Meisinger, Christine
    Hyhlik-Duerr, Alexander
    MEDICINA-LITHUANIA, 2023, 59 (04):
  • [8] Patterns of drug-related problems at hospital discharge with a focus on drug-drug interactions
    Studer, H.
    Cerone, R. C.
    Thurnherr, E. Hufschmid
    Portner, B.
    Boeni, F.
    Hersberger, K. E.
    Lampert, M. L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 248 - 248
  • [9] Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series
    Vazquez, Sara R.
    Wilson, Aaron S.
    Witt, Daniel M.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (04) : 583 - 586
  • [10] Nirmatrelvir/ritonavir: real world drug-drug interaction management experience
    Bukhari, Shahid
    Hughes, Stephen
    Mughal, Nabeela
    Moore, Luke S. P.
    Davies, Gary
    Zhang, Adrian Varghas
    Ng, Megan
    Karagozlu, Zekiye
    Boffito, Marta
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (09) : 781 - 783
12345